OpenLoc-L Spinal Fixation System, LnK Spinal Fixation System

K171813 · L&K BIOMED Co., Ltd. · NKB · Jul 13, 2017 · Orthopedic

Device Facts

• Record ID: K171813
• Device Name: OpenLoc-L Spinal Fixation System, LnK Spinal Fixation System
• Applicant: L&K BIOMED Co., Ltd.
• Product Code: NKB · Orthopedic
• Decision Date: Jul 13, 2017
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 888.3070
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

OpenLoc-L Spinal Fixation System is non-cervical spinal fixation devices intended for use as posterior pedicle screw fixation system (T1-S2/ilium), or as an anterolateral fixation system (T8-L5). All components in the system are limited to skeletally mature patients. These devices are indicated as an adjunct to fusion for all of the following indications regardless of the intended use: degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); deformities or curvatures (i.e., scoliosis, kyphosis); tumor, stenosis; and failed previous fusion (pseudoarthrosis). The OpenLoc-L Spinal Fixation System is a pedicle screw system indicated for the treatment of severe spondylolisthesis (Grades 3 and 4) of the L5-S1 vertebra in sketally mature patients receiving fusion by autogenous bone graft having implants attached to the lumbar and sacral spine (L3 to sacrum) with removal of the implants after the attainment of a solid fusion. In addition, the OpenLoc-L Spinal Fixation System is intended to provide immobilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine: degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, scoliosis, spinal tumor, and failed previous fusion (pseudoarthrosis).

Device Story

System comprises pedicle screws, set screws, rods, crosslinks, hooks, and connectors; used for spinal stabilization and immobilization. Components implanted by surgeons in clinical settings to provide rigid fixation as an adjunct to spinal fusion. Device provides mechanical support to spinal segments; facilitates fusion process; intended for removal after solid fusion attainment. Benefits include stabilization of acute/chronic instabilities and correction of deformities.

Clinical Evidence

Bench testing only. Pullout testing per ASTM F543-13 was performed on subject screws and compared to the predicate device to demonstrate equivalent mechanical performance.

Technological Characteristics

Materials: Titanium alloy (ASTM F136) and CoCrMo alloy (ASTM F1537). Components: screws (4.0-8.5mm diameter, 20-150mm length), rods, hooks, set screws. Non-sterile. Mechanical fixation system.

Indications for Use

Indicated for skeletally mature patients requiring non-cervical spinal fixation (T1-S2/ilium posterior or T8-L5 anterolateral) as an adjunct to fusion. Conditions include degenerative disc disease, spondylolisthesis (including severe L5-S1 grades 3-4), trauma, spinal deformities (scoliosis, kyphosis), tumor, stenosis, and failed previous fusion.

Regulatory Classification

Identification

(1) Rigid pedicle screw systems are comprised of multiple components, made from a variety of materials that allow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. Such a spinal implant assembly consists of a combination of screws, longitudinal members (e.g., plates, rods including dual diameter rods, plate/rod combinations), transverse or cross connectors, and interconnection mechanisms (e.g., rod-to-rod connectors, offset connectors).(2) Semi-rigid systems are defined as systems that contain one or more of the following features (including but not limited to): Non-uniform longitudinal elements, or features that allow more motion or flexibility compared to rigid systems.

Special Controls

*Classification.* (1) Class II (special controls), when intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra; degenerative spondylolisthesis with objective evidence of neurologic impairment; fracture; dislocation; scoliosis; kyphosis; spinal tumor; and failed previous fusion (pseudarthrosis). These pedicle screw spinal systems must comply with the following special controls:(i) Compliance with material standards; (ii) Compliance with mechanical testing standards; (iii) Compliance with biocompatibility standards; and (iv) Labeling that contains these two statements in addition to other appropriate labeling information: “Warning: The safety and effectiveness of pedicle screw spinal systems have been established only for spinal conditions with significant mechanical instability or deformity requiring fusion with instrumentation. These conditions are significant mechanical instability or deformity of the thoracic, lumbar, and sacral spine secondary to severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra, degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). The safety and effectiveness of these devices for any other conditions are unknown.” “Precaution: The implantation of pedicle screw spinal systems should be performed only by experienced spinal surgeons with specific training in the use of this pedicle screw spinal system because this is a technically demanding procedure presenting a risk of serious injury to the patient.” (2) Class II (special controls), when a rigid pedicle screw system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion in the treatment of degenerative disc disease and spondylolisthesis other than either severe spondylolisthesis (grades 3 and 4) at L5-S1 or degenerative spondylolisthesis with objective evidence of neurologic impairment. These pedicle screw systems must comply with the following special controls: (i) The design characteristics of the device, including engineering schematics, must ensure that the geometry and material composition are consistent with the intended use. (ii) Non-clinical performance testing must demonstrate the mechanical function and durability of the implant. (iii) Device components must be demonstrated to be biocompatible. (iv) Validation testing must demonstrate the cleanliness and sterility of, or the ability to clean and sterilize, the device components and device-specific instruments. (v) Labeling must include the following: (A) A clear description of the technological features of the device including identification of device materials and the principles of device operation; (B) Intended use and indications for use, including levels of fixation; (C) Identification of magnetic resonance (MR) compatibility status; (D) Cleaning and sterilization instructions for devices and instruments that are provided non-sterile to the end user; and (E) Detailed instructions of each surgical step, including device removal. (3) Class II (special controls), when a semi-rigid system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion for any indication. In addition to complying with the special controls in paragraphs (b)(2)(i) through (v) of this section, these pedicle screw systems must comply with the following special controls: (i) Demonstration that clinical performance characteristics of the device support the intended use of the product, including assessment of fusion compared to a clinically acceptable fusion rate. (ii) Semi-rigid systems marketed prior to the effective date of this reclassification must submit an amendment to their previously cleared premarket notification (510(k)) demonstrating compliance with the special controls in paragraphs (b)(2)(i) through (v) and paragraph (b)(3)(i) of this section.

Predicate Devices

• LnK Spinal Fixation System (K143363)

Submission Summary (Full Text)

{0}------------------------------------------------

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

L&K BIOMED Co., Ltd. Ms. Yerim An RA Manager #201. 202 16-25. Dongbaekjungang-ro 16 beon-gil Giheung-gu, Yongin-si, Gyeonggi-do, 17015 KOREA

July 13, 2017

Re: K171813

Trade/Device Name: OpenLoc-L Spinal Fixation System, LnK Spinal Fixation System Regulation Number: 21 CFR 888.3070 Regulation Name: Thoracolumbosacral pedicle screw system Regulatory Class: Class II Product Code: NKB, KWP, KWQ Dated: June 16, 2017 Received: June 19, 2017

Dear Ms. An:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR

{1}------------------------------------------------

Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely.

# Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K171813

### Device Name

OpenLoc-L Spinal Fixation System, LnK Spinal Fixation System

Indications for Use (Describe)

Indications for Use (Describe)

OpenLoc-L Spinal Fixation System is non-cervical spinal fixation devices intended for use as posterior pedicle screw fixation system (T1-S2/ilium), or as an anterolateral fixation system (T8-L5). All components in the system are limited to skeletally mature patients. These devices are indicated as an adjunct to fusion for all of the following indications regardless of the intended use: degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); deformities or curvatures (i.e., scoliosis, kyphosis); tumor, stenosis; and failed previous fusion (pseudoarthrosis).

The OpenLoc-L Spinal Fixation System is a pedicle screw system indicated for the treatment of severe spondylolisthesis (Grades 3 and 4) of the L5-S1 vertebra in sketally mature patients receiving fusion by autogenous bone graft having implants attached to the lumbar and sacral spine (L3 to sacrum) with removal of the implants after the attainment of a solid fusion.

In addition, the OpenLoc-L Spinal Fixation System is intended to provide immobilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine: degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, scoliosis, spinal tumor, and failed previous fusion (pseudoarthrosis).

Type of Use (Select one or both, as applicable)

| <span></span> Prescription Use (Part 21 CFR 801 Subpart D) | <span></span> Over-The-Counter Use (21 CFR 801 Subpart C) |
|------------------------------------------------------------|-----------------------------------------------------------|
|------------------------------------------------------------|-----------------------------------------------------------|

## CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## 510(k) SUMMARY

The following 510(k) summary is being submitted as required by 21 CFR 807.92(a):

| 1. Submitter: | L&K BIOMED Co., Ltd.<br>#201, 202 16-25, Dongbaekjungang-ro 16<br>beon-gil<br>Giheung-gu, Yongin-si, Gyeonggi-do, 17015<br>Korea<br>Phone. [phone]<br>e-mail: [e-mail] |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Yerim An |

Date prepared: July, 12, 2017

#### 2. Device Identification

| Trade Name | OpenLoc-L Spinal Fixation System<br>LnK Spinal Fixation System |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Common Name | Spinal Fixation Appliances |
| Product Code | NKB, KWP, KWQ |
| Regulatory Class | Class II |
| Classification Name | Thoracolumbosacral Pedicle Screw System, 21 CFR §888.3070<br>Spinal Interlaminal Fixation Orthosis, 21 CFR §888.3050<br>Spinal Intervertebral Body Fixation Orthosis, 21 CFR §888.3060 |

#### Purpose of 510(k) 3.

The L&K BIOMED Co. Ltd., here by submits this special 510(k): device modification to request a modification for our previous LnK Spinal Fixation System. The modifications are to add new components and new brand name. We believe these modifications are eligible for the Special 510(k) process since they have the same fundamental scientific technology and intended use as the predicate device.

#### Predicate or legally marketed devices which are substantially equivalent 4.

- LnK Spinal Fixation System K143363
#### Description of the Device 5.

This system is comprised of screws, set screws, rods, crosslink, Hook and connectors. The components of this system are manufactured by Titanium

{4}------------------------------------------------

alloy (Titanium-6Aluminum-4Vanadium ELI, per ASTM F136) and CoCrMo alloy (Cobalt-28Chromium-6Molybdenum, per ASTM F1537). The screws are available from 4.0 to 8.5mm diameters with lengths ranging from 20-150mm.

## Materials:

| Product | Material | Standard |
|-------------|-------------------------------------------------|------------|
| Screw | Ti-6Al-4V ELI | ASTM F136 |
| | Ti-6Al-4V ELI | ASTM F136 |
| Rod | Cobalt-28Chromium-6Molybdenum-<br>4Vanadium ELI | ASTM F1537 |
| Hook | Ti-6Al-4V ELI | ASTM F136 |
| Set Screw | Ti-6Al-4V ELI | ASTM F136 |
| Accessories | Ti-6Al-4V ELI | ASTM F136 |

Any implant components other than the rods are not manufactured from cobalt chrome.

#### Indication for Use 6.

OpenLoc-L Spinal Fixation System is non-cervical spinal fixation devices intended for use as posterior pedicle screw fixation systems (T1-S2/illum), or as an anterolateral fixation system (T8-L5). All components in the system are limited to skeletally mature patients. These devices are indicated as an adjunct to fusion for all of the following indications regardless of the intended use:

- degenerative disc disease (defined as discogenic back pain with degeneration of . the disc confirmed by history and radiographic studies);
- . spondylolisthesis;
- . trauma (i.e., fracture or dislocation);
- . deformities or curvatures (i.e., scoliosis, kyphosis, and/or lordosis);
- tumor: .
- . stenosis, and
- . failed previous fusion (pseudoarthrosis)

The OpenLoc-L Spinal Fixation System is a pedicle screw system indicated for the treatment of severe Spondylolisthesis (Grade 3 and 4) of the L5-S1 vertebra in skeletally mature patients receiving fusion by autogenous bone graft having implants attached to the lumbar and sacral spine (L3 to sacrum) with removal of the implants after the attainment of a solid fusion.

In addition, the OpenLoc-L Spinal Fixation System is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine: degenerative Spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, scoliosis, spinal tumor and failed previous fusion (pseudoarthrosis).

{5}------------------------------------------------

## 7. Comparison of the technological characteristics of the subject and the predicate device

| Applicant | L&K BIOMED Co.,Ltd. | L&K BIOMED Co.,Ltd. |
|-----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device<br>Name | OpenLoc-L Spinal Fixation System<br>LnK Spinal Fixation System | LnK Spinal Fixation System |
| | Subject Device | Predicate Device |
| 510K No. | | K143363 |
| Regulation<br>No. | 888.3050, 888.3070 | 888.3050, 888.3070 |
| Product<br>Code | KWQ,KWP,NKB | MNI, MNH,KWQ,KWP,NKB |
| Class | Class II | Class II |
| Material | Titanium alloy (ASTM F136)<br>CoCr Alloy (ASTM F1537) | Titanium alloy (ASTM F136)<br>CoCr Alloy (ASTM F1537) |
| Sterile | Non-sterile | Non-sterile |
| Rod | Dia: 5.0/5.5/6.0mm Length:40~600mm | Dia: 5.0/5.5/6.0mm Length:40~600mm |
| Screw | Dia:4.0~8.5mm Length:20-150mm | Dia:4.0~8.5mm Length:20-150mm |
| Hooks | Ramped Hook - 6.0 Rod(Narrow,<br>Standard, Wide)<br>General Hook - 6.0 Rod(Narrow,<br>Standard, Wide)<br>Pedicle Hook - 6.0 Rod(Narrow,<br>Standard, Wide)<br>Angled Hook - 6.0 Rod(Right, Left)<br>Offset Hook - 6.0 Rod(Right, Left) | Ramped Hook - 6.0 Rod(Narrow, Standard,<br>Wide)<br>General Hook - 6.0 Rod(Narrow, Standard,<br>Wide)<br>Pedicle Hook - 6.0 Rod(Narrow, Standard,<br>Wide)<br>Angled Hook - 6.0 Rod(Right, Left)<br>Offset Hook - 6.0 Rod(Right, Left) |
| Indication<br>for use | OpenLoc-L Spinal Fixation System<br>is<br>non-cervical<br>spinal fixation devices<br>intended for use as posterior pedicle<br>screw fixation systems (T1-S2/ilium), or<br>as an anterolateral fixation system (T8-<br>L5). All components in the system are<br>limited to skeletally mature patients.<br>These devices are indicated as an<br>adjunct to fusion for all of the following<br>indications regardless of the intended<br>use:<br>*degenerative disc disease (defined as<br>discogenic back pain with degeneration<br>of the disc confirmed by history and<br>radiographic studies);<br>*spondylolisthesis;<br>*trauma (i.e., fracture or dislocation);<br>*deformities or curvatures (i.e., scoliosis,<br>*kyphosis, and/or lordosis);<br>*tumor;<br>*stenosis, and<br>*failed previous fusion (pseudoarthrosis)<br>The OpenLoc-L Spinal Fixation System<br>is a pedicle screw system indicated for<br>the treatment of severe | LnK Spinal Fixation System is non-cervical<br>spinal fixation devices intended for use as<br>posterior pedicle screw fixation systems<br>(T1-S2/ilium), or as an anterolateral fixation<br>system (T8-L5). All components in the<br>system are limited to skeletally mature<br>patients. These devices are indicated as an<br>adjunct to fusion for all of the following<br>indications regardless of the intended use:<br>*degenerative disc disease (defined as<br>discogenic back pain with degeneration of<br>the disc confirmed by history and<br>radiographic studies);<br>*spondylolisthesis;<br>*trauma (i.e., fracture or dislocation);<br>*deformities or curvatures (i.e., scoliosis,<br>kyphosis, and/or lordosis);<br>*tumor;<br>*stenosis, and<br>*failed previous fusion (pseudoarthrosis)<br>The LnK Spinal Fixation System is a<br>pedicle screw system indicated for the<br>treatment of severe Spondylolisthesis<br>(Grade 3 and 4) of the L5-S1 vertebra in<br>skeletally mature patients receiving fusion |

{6}------------------------------------------------

The OpenLoc-L Spinal Fixation System shares technological characteristics similar to the predicate device. These characteristics include similar design, the same materials, substantially equivalent performance characteristics and the same intended use.

#### Performance Testing 8.

Pullout testing per ASTM F543-13 was performed on the subject screws and compared to a legally marketed predicate device. Results of the testing demonstrate substantially equivalent performance.

#### Conclusion 9.

The OpenLoc-L Spinal Fixation System is substantially equivalent to the device referenced above.